Volker Kraft

This inventor holds 7 USPTO granted patents and 4 published patent applications, plus 2 CIPO patents and 8 EPO patents. Top assignee: Sanofi. Active years: 2012-2016.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Volker Kraft. Retrieved from https://idiyas.com/inventor/volker-kraft

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 7 (Patent Applications = 4)

% Patents Active = 71.4

CIPO Patents = 2

EPO Patents = 8 (Patent Applications = 8)

Average Co-Inventor Count = 4.9

ph-index = 3

Forward Citations = 47(Granted Patents)

Company Filing History:

7 out of 1,549

Sanofi

patents

Years Active: 2012-2016

Loading Chart...

7 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 9440941 - Substituted chroman-6-yloxy-cycloalkanes and their use as pharmaceuticals (2016-09-13),

2. 8912224 - Substituted 2-(chroman-6-yloxy)-thiazoles and their use as pharmaceuticals (2014-12-16),

3. 8865906 - Process for the preparation of a compound useful as an inhibitor of TAFIa (2014-10-21),

4. 8716481 - Process for the preparation of 6-substituted-1-(2H)-isoquinolinones (2014-05-06),

5. 8674121 - Process for the production of benzofurans (2014-03-18),

6. 8658808 - Process for the production of dronedarone intermediates (2014-02-25),

7. 8334392 - Process for the production of artemisinin intermediates (2012-12-18),

Title: Volker Kraft: Innovator in Pharmaceutical Chemistry

Introduction

Volker Kraft is a distinguished inventor based in Frankfurt am Main, Germany. He has made significant contributions to the field of pharmaceutical chemistry, holding a total of seven patents. His work primarily focuses on compounds that target the sodium-calcium exchanger, which plays a crucial role in various cardiovascular disorders.

Latest Patents

Kraft's latest patents include innovative compounds such as substituted chroman-6-yloxy-cycloalkanes and substituted 2-(chroman-6-yloxy)-thiazoles. The first patent describes these compounds as inhibitors of the sodium-calcium exchanger (NCX), particularly subtype 1 (NCX1). These compounds are designed for the treatment of disorders where intracellular calcium homeostasis is disrupted, including arrhythmias, heart failure, and stroke. The patent also outlines processes for preparing these compounds and their pharmaceutical applications. Similarly, the second patent focuses on thiazoles that share the same therapeutic potential and applications.

Career Highlights

Volker Kraft is currently employed at Sanofi, a leading global healthcare company. His work at Sanofi has allowed him to further his research and development in pharmaceuticals, contributing to advancements in treatments for critical health issues.

Collaborations

Kraft has collaborated with notable colleagues such as Kai Rossen and Gerhard Kretzschmar. These partnerships have enhanced his research efforts and have been instrumental in the development of his patented compounds.

Conclusion

Volker Kraft's innovative work in pharmaceutical chemistry has led to significant advancements in the treatment of cardiovascular disorders. His contributions through patents and collaborations continue to impact the field positively.

Profile summary based on public USPTO records.